Summer Sale

50% off Premium Yearly

00days
00hrs
00mins
00secs

TSE:OTEX

Open Text (OTEX.TO)

31.06
+0.54 (1.77%)
as of Jun 12, 2026, 8:00:00 pm Market Open.
501 watching
0
Investor Insights
star iconJun 14, 2026, 12:00 am

This summary was created by AI, based on 20 opinions in the last 12 months.

Open Text (OTEX) faces significant challenges as the company navigates a disruptive AI landscape that is reshaping software pricing models and contract renewals. Experts highlight a recent selloff, with concerns about its growth strategy, predominantly driven by acquisitions that have not yielded substantial success. The stock has experienced technical breakdowns, slipping below key support levels, and the company's management changes add to investor uncertainty. Despite some potential for recovery, many experts suggest exploring higher-quality software companies with better execution and growth prospects. Overall, OTEX is perceived as struggling with organic growth while competing with stronger players in the industry.

consensus icon
Consensus
Avoid
valuation icon
Valuation
Overvalued
review icon
Similar
Salesforce, CRM
DON'T BUY

12-month price target of $48. More appealing, longer runway opportunities elsewhere.

HOLD

Coming into the low point it saw in 2022, trying to bounce off, so far so good. Earnings will either add to that momentum or do the opposite. He doesn't usually buy the day before earnings.

If earnings news is good, could easily see return to mid-high $50s, a big level of resistance in the past. If you own it, give them the benefit of the doubt. If not, hold off until they report.

PARTIAL BUY

Other companies in the space make more sense to him. Getting into AI in a big way. Not impacted by today's market dive too much. He has a 12-month price target of $49.25. Add in thirds here around $43, $41, and $39. (Shouldn't go below $37.50.)

Last earnings beat on top and bottom lines, but not on margins (32% vs. expected 36-37%). Capex with so many companies has just ballooned, as they try to be competitive.

BUY

Buying shares in recent market selloff. Latest earnings report not strong. However, business is very good. Would recommend holding for long term investors. Recent M&A has a lot of potential. Expecting higher margins and cash flow. 

DON'T BUY

Disaster the last 5 years, down about 40%. Should be doing better, given demands for software. Market did not like one expensive acquisition, hurt balance sheet, still not recovered. No interest.

CSU is the one for him. 

SELL

It has its moments from time to time, but overall hasn't been great for awhile. Part of the issue is it's still quite levered. There are other compounding machines, but this one just doesn't get the job done. Sell, and buy something like DSG or CSU.

DON'T BUY

He's looked at it and it's done a fairly good job. Would much prefer ENGH or CSU. And CSU is the clear market leader of companies that rely on acquisitions to drive growth.

HOLD
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

OTEX has been trading sideways over the past couple of years, and its recent earnings results sent the stock lower. It remains highly profitable with good free cash flow, and trades at a cheap valuation for a tech stock (8.3X forward earnings). Its low valuation makes it a HOLD, but we would not add and do not like the negative momentum here.
Unlock Premium - Try 5i Free

WAIT

Growth rates have really come down. It's taking longer to convert customers to cloud and AI. Good, long-term name that will be there. Better areas in AI elsewhere. Good at lower levels, but not here.

BUY

Owns shares in dividend fund. Will continue to hold. Downward guidance has prompted market selloff. Sales growing and appears business plan is strong. Recent management meetings presenting high quality of products.  New A.I. technology very impressive. Current trading multiple very attractive for investors. Consistent dividend growth with steady income at ~3%. 

WEAK BUY

They're trying to incorporate AI and haven't benefited from this AI boom. He's owned this for a while in his TFSA. Has been volatile, their free cash flow growth has been consistent and it's a quality name. Don't expect huge, sudden returns, but it's a good way to offer tech exposure.

BUY ON WEAKNESS
Trevor Rose’s Insights - Trevor’s most-liked answers from 5i Research

OTEX has total debt of $8.84B and net debt of $7.84B. Total debt to equity ratio is 2.2x and Total debt to EBITDA is 5.8x, so debt is definitely high and one reason for lower valuations. OTEX is currently paying a decent yield of 2.77% and looking at payout ratio from free cash flow over the last twelve months is 37%. We do not think there is much risk in the dividend at these levels. While debt is high, interest coverage ratios are more comforting with an EBIT/Interest Expense of 1.5x and EBITDA/Interest Expense of 2.6x. So while debt is at high levels, OTEX is generating enough adjusted earnings to cover payments. OTEX is also expected to see high growth this year and is benefiting from AI tailwinds. While OTEX's current year outlook for growth is good, beyond, 2024 things are expected to slow. The decline in share price it has seen could be attributed partially to debt concerns but also investors shifting to other tech/AI options that have longer runways for growth. 

OTEX shares some slight similarities with CSU and LMN just due to the broad software exposure that all the companies have. CSU of course has a huge suite of software offerings due to its acquisitive growth strategy so there is some overlap. OTEX has a significantly weaker balance sheet and growth outlook compared to CSU and LMN. While OTEX is very cheap right now, but it is fundementally weaker than the latter two and should be substantially cheaper. 
Unlock Premium - Try 5i Free

BUY

Likes it here. Low organic growth rate historically. Recent demo of Navigator with embedded AI was impressive.  Capable serial acquirer. Bread and butter are enterprise content-management platforms: recurring revenues, high retention, mission critical for the Global 10,000. Undemanding multiple. Compounds earnings in mid-teens. Value and growth.

Unspecified

Management deserves more credit. They made their biggest acquisition in history in 2022 which caused the stock to plummet. However they have managed to turn it around as they had claimed they could and are now getting some revenue growth from the acquisition.They have also paid down $2 billion in debt so have a better balance sheet. trades at 11X earnings.

DON'T BUY

Is growing this year, but long term and compared to peers lacks growth in the software consolidation space.

Showing 31 to 45 of 461 entries